This inhibition works by limiting cholesterol synthesis and disrupting the distal regulation of leukemia stem cell‐specific MYC enhancer chromatin, thereby suppressing oncogenic AKT1 signaling and reducing MYC expression [130]. Here, MYC is linked to leukemia.